AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Butterfly Network, Inc.
Video analysis: BFLY
All videosNo video analysis for this stock yet. Request one from our team.
News: BFLY
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Medical Systems, American Well and Butterfly Network have been highlighted in this Industry Outlook article.
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
INSP, AMWL and BFLY are positioned to gain from digital health and AI demand despite cybersecurity risks.
Butterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting.
Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly's Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI). Merge Labs was founded with the long-term mi.
Butterfly Network Director Phanstiel Buys $1.0 Million in Stock. Is This a Sign Investors Should Also Buy?
Louise S. Phanstiel acquired ~115,000 shares at $8.68 per share, representing a total transaction value of $1.0 million. The purchase increased the director's total equity holdings by 20% and indirect holdings by 62%.
Butterfly Network CEO Joseph Devivo Sells 68,346 Shares
68,346 shares were sold for ~$684,143 on August 10, 2026. The transaction represents a 0.89% reduction in direct equity holdings.
Butterfly Network's Co-Founder Wanted To Change The World, And He Is
Butterfly Network (BFLY) traces back to a not-so-modest aspiration of one co-founder, to change the world, and a fortunate introduction by his professor to a visionary tech entrepreneur. BFLY is doing that through its pioneering ultrasound on a chip. A scanner sends images to an iPhone or similar device. That makes ultrasound doable pretty much anywhere. That's a huge deal. Cumbersome logistics cause many to refrain from being scanned as regularly as they should, often to bad and sometimes tragic results.
Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, congratulates Dr. Erica Schwartz on her confirmation as director of the Centers for Disease Control and Prevention (CDC). Dr. Schwartz has served as a member of Butterfly Network's Board of Directors since 2021 and has stepped down from the Board effective August 5, 2026 in advance of assuming her n.
